Kiwon lafiyaShirye-shirye

"Amiksin": alamomi ga yin amfani da illa. "Amiksin" - abun da ke ciki

Na nufin "Amiksin" shi ne wani antiviral wakili, da kuma wani immunomodulator. Babban sakamako ne samar da interferon, wanda ya yi yãki kamuwa da cuta a cikin jiki. Shi ne ya kamata a lura da cewa da aikin na interferon ne musamman bambance bambancen, amma mafi muhimmanci shi ne daidai da anti-virus kariya. Bugu da kari, shi ne ake nufi da anti-ƙari kuma anti-da ake dasu kariya yana da radioprotective da immunomodulatory Properties. Saboda wannan dalili, da miyagun ƙwayoyi "Amiksin" domin su ikon sa interferon samarwa a cikin 'yan sau ya fi girma fiye da sauran kudi. Kawai sa, wannan inductor ne mafi sauri kuma yadda ya kamata ya mayar da rigakafi dauki na jiki, kazalika da ma'auni na da muhimmanci abubuwa na rigakafi da tsarin.

Drug "Amiksin". alamomi

Bigiren da miyagun ƙwayoyi ne quite m, amma akwai wasu cututtuka a wadda ta an wajabta, mafi sau da yawa:

  • magani na mura.
  • rike far a m kwayar numfashi cututtuka.
  • hadaddun far da kwayar raunuka na hanta parenchyma saboda da aikin activators nau'in A, B da C;
  • prophylactic gwamnati da ya kawar da hadarin da yanayi cututtuka.
  • kawar da mutum cytomegalovirus a cikin jini.
  • tasiri a kan siffofin herpetic kamuwa da cuta.

Bugu da kari, da miyagun ƙwayoyi "Amiksin" da ake amfani da su inganta rigakafi tsaron gida. Yana da muhimmanci a lura da cututtuka kamar chlamydia, da tarin fuka, mahara sclerosis, myelitis encephalitic da kuma wasu somatic raunuka cewa ci gaba a kan bango na wani immunosuppressive jihar da kwayoyin.

Yara suna kuma yarda su yi amfani da miyagun ƙwayoyi "Amiksin". Alamomi don amfani a wannan harka da aka sosai iyakance: m siffofin na mura da kuma m kwayar cututtuka. Bugu da kari, har zuwa shekaru 7, wannan magani ya kamata ba a yi amfani. Domin lura da hepatitis B a yara miyagun ƙwayoyi "Amiksin" shi ne kuma ba m. Wannan shi ne saboda cewa babban hadarin keta kafa kara Kwayoyin.

sashi

Saboda haka, mu yi la'akari da yadda za a yi "Amiksin" a cututtuka daban-daban:

  1. Far da kwayar Hepatitis a farkon kwanaki biyu sanya 1 kwamfutar hannu (125 MG) da sau daya a rana. Jiyya da aka sa'an nan ci gaba ga wani daban-daban makirci - 1 kwamfutar hannu (125 MG) sau uku a rana.
  2. Rigakafin hepatitis B: 1 kwamfutar hannu na 125 MG sau ɗaya a mako don watanni biyu.
  3. Jiyya na mura da kuma colds a manya: 1 kwamfutar hannu. (125 MG) da sau daya a rana na kwana biyu. Hudu more kwayoyi da ake dauka kowane sauran rana.
  4. Jiyya na mura da kuma colds a yara: 60 MG dauka sau daya a rana na kwana biyu. Hudu kwayoyi - sau daya a cikin kwanaki uku.
  5. Immunomodulation: 1 tab. (125 MG) sau uku a rana for watanni biyu.
  6. Herpes da kuma sauran cututtuka: 1 kwamfutar hannu. (125 MG) na kwana biyu, sa'an nan kuma duk sauran rana domin shida makonni.

tsarin

Bari mu bincika da miyagun ƙwayoyi "Amiksin". A abun da ke ciki ya hada da wani babban aiki sashi: tilorona (0.06 g ko 0,125 g). Sauran gyara an dauke a cikin ƙananan maida hankali: alli hydrogen phosphate dihydrate, microcrystalline cellulose, hydroxypropyl methylcellulose, croscarmellose sodium, talc, dankalin turawa, sitaci, aerosil, polyvinylpyrrolidone, alli stearate, titanium dioxide, Madame Kandurin, colorants.

sakamako daga cikin miyagun ƙwayoyi

Bisa ga bayanai, da miyagun ƙwayoyi "Amiksin" ƙwayoyin cuta ba daidaita. Wannan shi ne wani muhimmin batu, ba da yiwuwar maye gurbi da karbuwa.

Yana nufin tasiri a lura da yawa kwayar cututtuka. Saboda haka, a hepatitis magani za a iya yi nan da nan ya inganta haƙuri da kiwon lafiya, kazalika da sauri dawo da hanta nama.

Idan da miyagun ƙwayoyi da ake amfani da matsayin rigakafin cututtuka, shi muhimmanci rage samu damar cutar kamuwa da cuta.

contraindications

Wannan mutum ji na ƙwarai to da miyagun ƙwayoyi, da shekaru 7 shekaru, a lokacin daukar ciki da kuma lactation.

illa

A wasu lokuta, ta bayyana gajere zazzabi, zawo sabon abu. Sosai da wuya faru rashin lafiyan halayen kamar urticaria, itching, da kuma fata rashes.

tsõratar

Kamar yadda da gwaninta na aikace-aikace na kudi a lokacin da juna biyu da kuma lactation ba yanzu, an ba da shawarar a wannan lokacin. A cikin ikon fitar da motocin ba zai tasiri magani.

The hulda da miyagun ƙwayoyi da sauran kwayoyi

Yana iya a haɗe shi da maganin rigakafi da kuma liyafar wajen al'ada far da kwayar kuma kwayan cututtuka.

yawan abin sama

Irin haka an san.

miyagun ƙwayoyi analogues

Domin da yawa, wani gagarumin cikas ga saye kudin da miyagun ƙwayoyi ne "Amiksin" miyagun ƙwayoyi. Alamomi ga yin amfani da wasu jamiái kama, da kuma farashin - araha. Daya daga cikin mafi kowa zabin - wani magani "Lavomax". Ya samar a cikin nau'i na alluna ga 0.125 g

A wasu lokuta, sauyawa zai iya zama a matsayin wata hanya ta "Ingavirin", amma da ikon yinsa yana da iyaka zuwa ga rigakafin, da kuma lura da SARS, mura, adenovirus.

Akwai sauran analogues "Amiksin" miyagun ƙwayoyi. Alamomi ga amfani, farashin, kuma kewayon mataki ne daban-daban. Amma wadannan mafi araha analogues za a iya amfani da magani na da yawa cututtuka. Wannan shi ne wani "Anaferon" shirye-shirye "Kagocel", "Oscillococcinum". Cost "Amiksin" wajen dabam dangane da taro na aiki sashi da kuma yawan Allunan a cikin kunshin. M farashin - 500 rubles. Na nufin "Lavomax" Kudinsa 400 rubles, yana nufin "Anaferon" - 150-200 rubles. Bambanci ne muhimmi, da sakamako a lokuta da dama ne irin wannan.

A kadan tarihi

Mun sake nazari da miyagun ƙwayoyi "Amiksin" alamomi don amfani, hanyoyi na ta liyafar. Yanzu shi wajibi ne don saka da yadda aka halitta wannan miyagun ƙwayoyi. Da miyagun ƙwayoyi ci gaba a shekarar 1975 a Odessa. Wasu shaida da shawara cewa shi ne domin na Main Leken Asiri Directorate inganta maza kiwon lafiya. Yana nufin akai-akai nazari a wani asibiti likita makaranta, kazalika a Cibiyar Oncology. Kavetsky. A kara gwaje-gwajen, da kuma cikakken nazari da za'ayi a cikin goma sauran likita da cibiyoyin bincike na Ukraine da kuma Rasha.

Similar articles

 

 

 

 

Trending Now

 

 

 

 

Newest

Copyright © 2018 ha.birmiss.com. Theme powered by WordPress.